Biotech Experts: Inflation Reduction Act to Impact R&D
TL/DR -
The Inflation Reduction Act (IRA), introduced in 2022, permits Medicare to negotiate prices and rebates for certain drugs, which has sparked concerns over reductions in innovation and R&D in the biotech and pharma industries. The Act's different timelines for price negotiations for large and small molecule therapeutics may make the…